Resource Center Title

Click here to register for this event

Improving Admission-Free Survival in Persistent Hypercapnic COPD Resource Center: Activity Two

 

Activity Title

Long-term Noninvasive Ventilation for Patients with stable Hypercapnic COPD
Prof. Dr. med. Michael Dreher

 

Program Goals

The purpose of this educational activity is to understand the current indications for long-term noninvasive ventilation (NIV) in patients with chronic obstructive pulmonary disease (COPD). Furthermore, additional emphasis will be placed on the outcome of COPD patients suffering from acute hypercapnic respiratory failure once the acute phase has been successfully treated and those patients have been sent home. Finally, the evidence for the long-term use of NIV after an acute hypercapnic exacerbation of COPD will be displayed. This program can be used as a stand alone education to increase clinicians’ knowledge of clinical indications, evidence and approaches to use NIV in the home environment of COPD patients. Furthermore, it is a perfect transition to the other presentations within this activity about the HOT HMV trial.

Target Audience

This activity is intended for medical professional who have a clinical interest in the management of COPD patients as seen by the following medical specialists: Pulmonologists, Pneumologists, Respirologists, Respiratory Physiotherapists, Respiratory Therapists (Hospital, Home), Thoracic Surgeons, Home Healthcare Providers, Critical Care Medicine Specialists, Internal Medicine Specialists, Primary Care Physicians (General and Family Practitioners), Advanced Practice Nurses, Nurse Practitioners, Physicians Assistants, Managed Care Medical Directors, and other Practitioners and Payers.

Learning Objectives

After completion of this activity, participants will be able to: 

  1. Understand the importance of applying a specific treatment strategy of noninvasive ventilation in stable hypercapnic COPD patients.
  2. Understand the benefits and outcomes of noninvasive ventilation in stable hypercapnic COPD patients.
  3. Understand the problematic long-term outcome of COPD patients after acute hypercapnic exacerbation has been treated sucessfully
  4. Discuss the indication of long-term NIV after acute hypercapnic respiratory failure due to COPD

Faculty

Gerard J. Criner, MD, FACP, FACCP
Professor and Chair
Department of Thoracic Medicine and Surgery
Lewis Katz School of Medicine at Temple University
Philadelphia, PA

Prof. Dr. med. Michael Dreher
Department of Cardiology, Pneumology, Angiology and Intensive Care
University Hospital Aachen
Germany

Prof. Nicholas Hart
Professor in Respiratory & Critical Care Medicine
Director of Lane Fox Respiratory Service
Director of Research Delivery
St Thomas’ Hospital
Guys & St Thomas’ NHS Foundation Trust
London UK

Patrick Murphy, MD
Consultant Lane Fox Respiratory Service
St Thomas’ Hospital
Guys & St Thomas’ NHS Foundation Trust
London UK

Educational Activity Agenda

Long-term Noninvasive Ventilation for Patients with stable Hypercapnic COPD

  • Front Matter and Registration (3 minutes)
  • Faculty Introduction, Presentations and Roundtable Discussions (47 minutes)
  • Post Test, Evaluation, and Credit Application (10 minutes)

Release and Expiration Dates

Enduring Archive Release Date: July 21, 2017
Enduring Archive Expiration Date: July 21, 2019

Disclosure of Conflicts of Interests

Global Education Group requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosures

The faculty reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gerard J. Criner, MD

  • Honoraria: None
  • Grants received: NIH-NHLBI, PA-DOH,GSK, Boehringer- Ingelheim, Novartis, Astra Zeneca, Respironics, Pearl, PneumRx, Pulmonx, ResMed, Mereo,Probioterix, Broncus, Spiration.
  • Grants pending: NIH-NHLBI, Fisher Paykel
  • Consultation: Amirall, Holaira, Boehringer –Ingelheim, Astra Zeneca, Respironics, Mereo, Patara

Michael Dreher, MD

  • Consultant: ResMed, Philips Respironics, Linde
  • Grant/Research Support: ResMed
  • Honoraria: ResMed, Philips Respironics, Weinmann, Hamilton, Linde 

Nicholas Hart, MD

  • Honoraria and Consultant: Astra Zeneca, GSK, Philips-Respironics; ResMed, B&D Electromedical; Fisher-Paykel
  • Grant/Research Support: ResMed, Philips-Respironics, Fisher-Paykel Healthcare, B&D ElectroMedical
  • Company Sponsored Bureau: Philips-Respironics  and ResMed

Patrick Murphy, MD

  • Honoraria and Consultant: Philips-Respironics; ResMed; B&D electromedical; Fisher-Paykel
  • Grant/Research Support: ResMed, Abingdon, Oxfordshire, UK; Philips-Respironics, Murrysville, PA, USA; Fisher & Paykel Healthcare, Auckland, New Zealand and B&D ElectroMedical, Stratford-upon-Avon, Warwickshire, UK
  • Advisory Board: Philips-Respironics; ResMed; B&D electromedical; Fisher-Paykel

Planners and Managers

The planners and managers reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN

  • Nothing to disclose

Lindsay Borvansky

  • Nothing to disclose

Andrea Funk

  • Nothing to disclose

Laura Gilsdorf

  • Nothing to disclose

Gail Varcelotti, BS, RRT, FAARC

  • Nothing to disclose

CME Provider Accreditation Statement

This activity is provided by Global Education Group.     

Physician Accreditation Statement - CME

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

*This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation - CME

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.  

This educational activity for up to 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Global Education Group

For information about the physician accreditation for this activity, please contact Global Education Group at (303) 395-1782, or inquire@globaleducationgroup.com.

How to Obtain CME/CE Credit

Attendees are expected to view the entire activity before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit™. To receive credit, the course must be completed between July 21, 2017 and July 21, 2019.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME/CE credit for viewing the webcast:

  • Read all of the CME/CE accreditation information above.
  • View the complete electronic (web) activity.
  • Click on the link to apply for CME/CE credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity. 

Should you have any CME/CE questions regarding this activity, please contact:

Global Education Group
5575 S. Sycamore Street, Suite 200
Littleton, CO 80120
Phone: 303-395-1782
Fax: 303-648-5311
Email: inquire@globaleducationgroup.com
Web: www.globaleducationgroup.com

 

Credit Designation - AARC

This Non-traditional program has been approved for 1.0 contact hour Continuing Respiratory Care  Education (CRCE) credit by the American Association for Respiratory Care; 9425 N. MacArthur Boulevard, Suite 100, Irving TX 75063

How to Obtain AARC / CRCE Credit

Attendees are expected to review all academic materials before attempting to apply for credit. Successful completion of this activity will lead to the issuance of a certificate for 1.0 contact hour of CRCE approved continuing education.

To receive credit, please follow these steps:

  • Complete the online registration (registration is free).
  • Review all of the academic materials provided.
  • Click on the CRCE link to apply for credit.
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
  • Qualified applicants will be provided with an online (printable) CRCE certificate based on their attendance and satisfactory completion of this academic activity.

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Global Education Group protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global Education Group and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Global Education Group, CHEST, Elsevier, and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your non-public personal information.

Medium Used

This program has been made available online.
"Long-term Noninvasive Ventilation for Patients with stable Hypercapnic COPD"

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Commercial Support Statement

This online Resource Center is supported by an Educational Grant from Philips Respironics, Inc.

Copyright

Copyright© 2017 American College of Chest Physicians. All Rights Reserved. Permission for accreditation use granted to Global Education Group (Global). Web interface provided by Dane Garvin Ltd.